Scientists have long believed that a newborn’s immune system was an immature version of an adult’s, but new research from Cornell University shows that newborns’ T cells – white blood cells that protect from disease – outperform those of adults at fighting off numerous infections.
FDA Withdraws Approval of FGFR Inhibitor for Bile Duct Cancer
The FDA has withdrawn the approval of infigratinib (Truseltiq) as a second-line treatment for metastatic cholangiocarcinoma at the request of the drugmaker, the agency announced
May 21, 2024